Reduced Implementation and Completion of Average-Risk Annual Fecal Immunochemical Test Colorectal Cancer Screening in Black Patients Aged 45-49 Years.
作者信息
Coronado Gloria D, Dickerson John F, Burnett-Hartman Andrea N, Carethers John M, Lee Jeff K, McBurnie Mary Ann
机构信息
Kaiser Permanente Center for Health Research, Portland, Oregon.
Kaiser Permanente Center for Health Research, Portland, Oregon.
出版信息
Clin Gastroenterol Hepatol. 2023 Jul;21(7):1937-1939. doi: 10.1016/j.cgh.2022.05.009. Epub 2022 May 27.
Abstract
摘要
相似文献
1
Reduced Implementation and Completion of Average-Risk Annual Fecal Immunochemical Test Colorectal Cancer Screening in Black Patients Aged 45-49 Years.45至49岁黑人患者平均风险年度粪便免疫化学检测结直肠癌筛查的实施率和完成率降低。
Clin Gastroenterol Hepatol. 2023 Jul;21(7):1937-1939. doi: 10.1016/j.cgh.2022.05.009. Epub 2022 May 27.
2
Optimal use of colonoscopy and fecal immunochemical test for population-based colorectal cancer screening: a cost-effectiveness analysis using Japanese data.基于人群的结直肠癌筛查中结肠镜检查和粪便免疫化学检测的优化使用：一项使用日本数据的成本效益分析
Jpn J Clin Oncol. 2016 Feb;46(2):116-25. doi: 10.1093/jjco/hyv186. Epub 2015 Dec 18.
3
Enhancing Colorectal Cancer Screening Specificity by Integrating Fecal MicroRNA Signature With Fecal Immunochemical Test and Fecal Occult Blood Test.
Gastroenterology. 2024 Feb;166(2):358. doi: 10.1053/j.gastro.2023.06.012. Epub 2023 Jun 17.
4
FECAL OCCULT BLOOD: A COMPARISON OF CHEMICAL AND IMMUNOCHEMICAL TESTS.粪便潜血：化学检测与免疫化学检测的比较
Arq Gastroenterol. 2018 Apr-Jun;55(2):128-132. doi: 10.1590/S0004-2803.201800000-22.
5
Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion: A Randomized Clinical Trial.结肠镜检查外展与粪便免疫化学检测外展对结直肠癌筛查完成率的影响：一项随机临床试验。
JAMA. 2017 Sep 5;318(9):806-815. doi: 10.1001/jama.2017.11389.
6
Is Promotion of Fecal Immunochemical Testing "FIT" to Address COVID-19 Disruptions to Colorectal Cancer Screening?推广粪便免疫化学检测（FIT）以应对新冠疫情对结直肠癌筛查的干扰？
Gastroenterology. 2022 May;162(6):1761-1762. doi: 10.1053/j.gastro.2021.11.030. Epub 2021 Dec 1.
7
Fecal Immunochemical Tests: The Right Colorectal Cancer Screening Test for the Average-Risk Population?粪便免疫化学检测：适用于平均风险人群的正确结直肠癌筛查检测方法？
Clin Gastroenterol Hepatol. 2022 Oct;20(10):2216-2217. doi: 10.1016/j.cgh.2022.03.030. Epub 2022 Apr 4.
8
Colorectal Cancer Screening by Colonoscopy, CT-Colonography, or Fecal Immunochemical Test.通过结肠镜检查、CT结肠成像或粪便免疫化学检测进行结直肠癌筛查。
J Natl Cancer Inst. 2015 Dec 30;108(2). doi: 10.1093/jnci/djv383. Print 2016 Feb.
9
A combination of clinical risk stratification and fecal immunochemical test is useful for identifying persons with high priority of early colonoscopy.联合临床风险分层和粪便免疫化学检测有助于识别具有早期结肠镜检查高优先级的人群。
Dig Liver Dis. 2018 Mar;50(3):254-259. doi: 10.1016/j.dld.2017.11.002. Epub 2017 Nov 15.
10
Cost-effectiveness and budget impact analyses of colorectal cancer screenings in a low- and middle-income country: example from Thailand.在中低收入国家进行结直肠癌筛查的成本效益和预算影响分析：来自泰国的例子。
J Med Econ. 2019 Dec;22(12):1351-1361. doi: 10.1080/13696998.2019.1674065. Epub 2019 Oct 12.
引用本文的文献
1
Trends and Symptoms Among Increasing Proportion of African Americans with Early-Onset Colorectal Cancer over a 60-Year Period.60年间早发性结直肠癌的非裔美国人比例上升过程中的趋势与症状
Dig Dis Sci. 2025 Jan;70(1):168-176. doi: 10.1007/s10620-024-08739-5. Epub 2024 Nov 25.
2
Impact of racial disparities in follow-up and quality of colonoscopy on colorectal cancer outcomes.种族差异对结肠镜检查随访和质量对结直肠癌结果的影响。
J Natl Cancer Inst. 2024 Nov 1;116(11):1807-1816. doi: 10.1093/jnci/djae140.
3
The effect of mailed outreach on FIT completion among patients aged 45-50 in a safety net healthcare system.在一个医疗保障体系中，邮寄外展对 45-50 岁患者完成粪便免疫化学检测的影响。
Cancer Causes Control. 2024 Oct;35(10):1311-1317. doi: 10.1007/s10552-024-01889-x. Epub 2024 Jun 1.
4
Commencing colorectal cancer screening at age 45 years in U.S. racial groups.在美国不同种族群体中从45岁开始进行结直肠癌筛查。
Front Oncol. 2022 Jul 22;12:966998. doi: 10.3389/fonc.2022.966998. eCollection 2022.
本文引用的文献
1
Racial and ethnic disparities in colorectal cancer incidence and mortality.结直肠癌发病率和死亡率的种族和民族差异。
Adv Cancer Res. 2021;151:197-229. doi: 10.1016/bs.acr.2021.02.007. Epub 2021 May 5.
2
Black and White Differences in Colorectal Cancer Screening and Screening Outcomes: A Narrative Review.黑白人群在结直肠癌筛查及筛查结局方面的差异：一项叙述性综述。
Cancer Epidemiol Biomarkers Prev. 2021 Jan;30(1):3-12. doi: 10.1158/1055-9965.EPI-19-1537. Epub 2020 Nov 3.
3
Early Screening of African Americans (45-50 Years Old) in a Fecal Immunochemical Test-Based Colorectal Cancer Screening Program.以粪便免疫化学试验为基础的结直肠癌筛查方案中对 45-50 岁非裔美国人的早期筛查。
Gastroenterology. 2020 Nov;159(5):1695-1704.e1. doi: 10.1053/j.gastro.2020.07.011. Epub 2020 Jul 20.
4
Causes of Socioeconomic Disparities in Colorectal Cancer and Intervention Framework and Strategies.社会经济差异导致结直肠癌的原因及干预框架和策略。
Gastroenterology. 2020 Jan;158(2):354-367. doi: 10.1053/j.gastro.2019.10.029. Epub 2019 Nov 1.
5
Clinical and Genetic Characteristics of Colorectal Cancer in Persons under 50 Years of Age: A Review.50 岁以下人群结直肠癌的临床和遗传特征：综述。
Dig Dis Sci. 2019 Nov;64(11):3059-3065. doi: 10.1007/s10620-019-05644-0. Epub 2019 May 4.
6
Colorectal Cancer Incidence Trends by Age, Stage, and Racial/Ethnic Group in California, 1990-2014.加利福尼亚州 1990-2014 年按年龄、分期和种族/族裔划分的结直肠癌发病率趋势
Cancer Epidemiol Biomarkers Prev. 2018 Sep;27(9):1011-1018. doi: 10.1158/1055-9965.EPI-18-0030. Epub 2018 Aug 16.
Zotero 插件